Health Catalyst, Inc.
HCAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $306,584 | $295,938 | $276,236 | $241,926 |
| % Growth | 3.6% | 7.1% | 14.2% | – |
| Cost of Goods Sold | $165,805 | $164,105 | $143,049 | $124,354 |
| Gross Profit | $140,779 | $131,833 | $133,187 | $117,572 |
| % Margin | 45.9% | 44.5% | 48.2% | 48.6% |
| R&D Expenses | $57,950 | $72,627 | $75,680 | $62,733 |
| G&A Expenses | $56,817 | $76,559 | $61,701 | $85,934 |
| SG&A Expenses | $111,204 | $143,880 | $149,215 | $160,961 |
| Sales & Mktg Exp. | $54,387 | $67,321 | $87,514 | $75,027 |
| Other Operating Expenses | $41,431 | $42,223 | $48,297 | $37,528 |
| Operating Expenses | $210,585 | $258,730 | $273,192 | $261,222 |
| Operating Income | -$69,806 | -$126,897 | -$140,005 | -$143,650 |
| % Margin | -22.8% | -42.9% | -50.7% | -59.4% |
| Other Income/Exp. Net | $637 | $9,106 | -$1,678 | -$16,458 |
| Pre-Tax Income | -$69,169 | -$117,791 | -$141,683 | -$160,108 |
| Tax Expense | $333 | $356 | -$4,280 | -$6,898 |
| Net Income | -$69,502 | -$118,147 | -$137,403 | -$153,210 |
| % Margin | -22.7% | -39.9% | -49.7% | -63.3% |
| EPS | -1.15 | -2.09 | -2.56 | -3.23 |
| % Growth | 45% | 18.4% | 20.7% | – |
| EPS Diluted | -1.15 | -2.09 | -2.54 | -3.23 |
| Weighted Avg Shares Out | 60,185 | 56,418 | 53,722 | 47,495 |
| Weighted Avg Shares Out Dil | 60,185 | 56,418 | 54,080 | 47,495 |
| Supplemental Information | – | – | – | – |
| Interest Income | $17,982 | $16,389 | $5,687 | $831 |
| Interest Expense | $17,086 | $7,287 | $7,239 | $17,313 |
| Depreciation & Amortization | $41,431 | $42,223 | $51,528 | $41,113 |
| EBITDA | -$10,652 | -$68,281 | -$82,916 | -$101,682 |
| % Margin | -3.5% | -23.1% | -30% | -42% |